StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Ajit Mishra, Religare

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byAjit Mishra, ReligareHorizon: Swing (≤2wk)9 Sept 2026via NDTV Profit (Live)

Entry₹2,486.9Inferred
Target₹2,580
Total upside +3.74% (call closed)
Stop loss₹2,420-2.69% risk
Exit₹2,4209 Sept 2026, 10:00 am
Stop-loss hit-2.69%
Follow Ajit Mishra for new calls(23% target hit, 114 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 209 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Sept 2026
3 supporting3 neutral0 opposing
Supports the BUY call (3)

10 midcap stocks with over 150% profit growth in Q1FY27

NewsEt-Markets·6 Sept · 2d ago

(opens in new tab)

Is Nifty set for a breakout? Analysts see signs of a shift ahead

NewsEt-Markets·31 Aug · 1w ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·20 Aug · 3w ago

Neutral / worth noting (3)

Buy, Sell Or Hold: Vishal Mega Mart, HDFC Bank, Shriram Finance, Ather Energy And Glenmark Pharma — Ask Profit

NewsNdtv-Profit·31 Aug · 1w ago

(opens in new tab)

Corporate Actions This Week: Coal India, ONGC, Glenmark Pharma, GAIL, Nirlon — Check Full List Here

NewsNdtv-Profit·30 Aug · 1w ago

(opens in new tab)

Glenmark Pharma, Mastek, Triveni Engineering Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·28 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Ajit Mishra, Religare

Every call and its outcome